Chemoinformaics analysis of 11-Methylgerberinol
| Molecular Weight | 378.38 | nRot | 2 |
| Heavy Atom Molecular Weight | 360.236 | nRig | 24 |
| Exact Molecular Weight | 378.11 | nRing | 4 |
| Solubility: LogS | -4.191 | nHRing | 2 |
| Solubility: LogP | 4.456 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 20 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 22 |
| nHA | 6 | APOL | 53.5543 |
| nHD | 2 | BPOL | 23.2657 |
| QED | 0.51 |
| Synth | 2.854 |
| Natural Product Likeliness | 0.5 |
| NR-PPAR-gamma | 0.979 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.091 |
| Pgp-sub | 0.998 |
| HIA | 0.017 |
| CACO-2 | -4.994 |
| MDCK | 0.0000246 |
| BBB | 0.019 |
| PPB | 0.998727 |
| VDSS | 0.269 |
| FU | 0.0200121 |
| CYP1A2-inh | 0.59 |
| CYP1A2-sub | 0.972 |
| CYP2c19-inh | 0.858 |
| CYP2c19-sub | 0.281 |
| CYP2c9-inh | 0.926 |
| CYP2c9-sub | 0.963 |
| CYP2d6-inh | 0.459 |
| CYP2d6-sub | 0.383 |
| CYP3a4-inh | 0.184 |
| CYP3a4-sub | 0.249 |
| CL | 0.597 |
| T12 | 0.068 |
| hERG | 0.007 |
| Ames | 0.049 |
| ROA | 0.439 |
| SkinSen | 0.559 |
| Carcinogencity | 0.197 |
| EI | 0.123 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.865 |
| Antiviral | Yes |
| Prediction | 0.626898 |